Trial Profile
Beta cell function and Glycaemic control with saxagliptin and acarbose as add-on therapy to metformin in older Chinese patients with type-2 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Feb 2016
Price :
$35
*
At a glance
- Drugs Acarbose (Primary) ; Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 28 Jan 2015 New trial record